 |
 |
http://www.nytimes.com/2015/11/21/us/politics/administration-is-seeking-ways-to-keep-prescription-drugs-affordable.html?_r=0 Here's an article from the NYTimes (Nov. 21) that focuses on costs but does not mention nilotinib or the Georgetown study. The reporter does quote the president of Novartis. I wrote to the reporter. Hope to hear back from him. Kathleen P.S. Maybe the reason the video does not mention costs is that it comes from a Canadian broadcaster! Not a big issue there. Wish we in the US could say the same. On 4 December 2015 at 02:08, Nic Marais <[log in to unmask]> wrote: > No mention of costs...;-) > > Nic 63/21 > > On 3 December 2015 at 19:11, Rayilyn Brown <[log in to unmask]> wrote: > > > > > > http://www.ctvnews.ca/health/cancer-drug-shows-promise-for-reversing-symptoms-of-parkinson-s-disease-1.2615703 > > Ray > > Rayilyn Brown > > Past Director AZNPF > > Arizona Chapter National Parkinson Foundation > > > > ---------------------------------------------------------------------- > > To sign-off Parkinsn send a message to: mailto: > > [log in to unmask] > > In the body of the message put: signoff parkinsn > > > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto: > [log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn